欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IS/H/0415/001
药品名称Zelvina
活性成分
    • lenalidomide 2.5 mg
剂型Capsule, hard
上市许可持有人AdAlvo Limited Malta Life Sciences Park Building 1, Level 4 Sir Temi Zammit Buildings San Gwann Industrial Estate, San Gwann SGN 3000, Malta
参考成员国 - 产品名称Iceland (IS)
Zelvina
互认成员国 - 产品名称
    • Malta (MT)
许可日期2020/07/17
最近更新日期2023/07/13
药物ATC编码
    • L04AX04 lenalidomide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase